About Versono
Versono is a company based in Galway (Ireland) founded in 2019 by Finbar Barry Dolan. Versono has raised $7.05 million across 1 funding round from investors including Bessemer Venture Partners, Enterprise Ireland and Western Development Commission. Versono operates in a competitive market with competitors including Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
- Headquarter Galway, Ireland
- Founders Finbar Barry Dolan
- SectorsHealthcare
- Website versono.life
- Total Equity Funding$7.05M (USD)
in 1 rounds
- Latest Funding Round$7.05M (USD), Series A
May 2022
- InvestorsBessemer Venture Partners
& 3 more
Funding Insights of Versono
Versono has successfully raised a total of $7.05M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.05 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.05M
- Total Rounds 1
- Last Round Series A — $7.05M
- First Round $7.05M
(May 2022)
- Investors Count 4
All 1 funding rounds of Versono with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $7.05M | Series A | – | Bessemer Venture Partners, Western Development Commission |
4 investors in total: 4 institutional.
Investors in Versono
Versono has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Bessemer Venture Partners, Enterprise Ireland and Western Development Commission.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | bvp.com | Redwood City, United States | |
Private equity & debt fund investing in multiple sectors | 1997 | westerndevelopment.ie | Ballaghaderreen, Ireland | |
Moore Ireland is recognized as a leading accounting firm. | – | dhkn.ie | Dublin, Ireland | |
Support is provided to Irish manufacturing and service sector businesses. | 1998 | enterprise-ireland.com | Dublin, Ireland |
Investor details for Versono
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Versono
2 people are tracked at Versono (2 in leadership).
| Name | Role | Group |
|---|---|---|
Finbar Barry Dolan | Founder & CEO | Leadership |
Finbar Dolan | CEO | Leadership |
Complete people profiles for Versono
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Versono
2 dated milestones of Versono across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Versono is founded.
- Funding First funding round of $7.0M.
Competitors of Versono
Versono operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, LeMaitre Vascular, Okami Medical, Cagent Vascular and Pathway Medical Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avinger.com | 2007 | Redwood, United States | $170.85M | 80 | Provider of image-guided catheter-based products for peripheral artery disease | |
| lemaitre.com | 1983 | Burlington, United States | $5.83M | 317 | Devices for peripheral vascular disease treatment are developed and marketed. | |
| okamimedical.com | 2011 | Aliso Viejo, United States | $62.09M | – | Innovative medical devices for peripheral vessel treatment are developed. | |
| cagentvascular.com | 2014 | Wayne, United States | $69.42M | – | Devices for removing vascular blockages are developed. | |
| pathwaymedical.com | 1998 | Kirkland, United States | $101.93M | 158 | Smart devices are provided to clear peripheral arterial blockages. | |
| intactvascular.com | 2011 | Wayne, United States | $123.4M | 64 | Implants for repairing arteries after angioplasty are developed. | |
| venturemedgroup.com | 2012 | Toledo, United States | $51.05M | – | Endovascular devices are developed for PAD and AV fistula treatments. | |
| truvic.com | 2014 | Campbell, United States | $5.89M | – | Smart devices for peripheral vascular thrombus management are developed. | |
| atheromedinc.com | 2006 | Menlo Park, United States | $24.67M | – | Peripheral atherectomy catheter for peripheral arterial disease | |
| pqbypass.com | 2011 | Mountain View, United States | $71.67M | 1 | Percutaneous approach for femoral artery bypass |
Detailed competitors of Versono
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Versono
The website of Versono (versono.life) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 426.4% vs previous month
Latest news on Versono
Complete news archive for Versono
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Versono
10 companies that operate in the same segment as Versono (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Versono
Versono was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Versono is headquartered in Galway, Ireland.
Finbar Barry Dolan is the current CEO of Versono. They have also founded this company.
Versono is a funded company, having raised a total of $7.05M across 1 funding round to date. The company's 1st funding round was a Series A of $7.05M, raised on May 2022.
Versono was founded in 2019 in Galway, Ireland, within the medical technology sector. Therapeutic solutions for peripheral arterial disease are developed, with emphasis on an intravascular ultrasonic platform for endovascular surgery. Severe occlusions in patients with critical limb ischemia are addressed to reduce pain and preserve limbs. Operations center on advancing these technologies for clinical applications.
Versono's top competitors include Avinger, Okami Medical and Cagent Vascular.
Versono has 4 investors. Key investors include Bessemer Venture Partners, Enterprise Ireland, Western Development Commission, and Moore Ireland.